LYSP100-associated nuclear domains (LANDs): Description of a new class of subnuclear structures and their relationship to PML nuclear bodies

Blood

Volumn 88, Issue 4, 1996, Pages 1423-1436

  Dent, Alexander L ^b   Yewdell, Jonathan ^b   Puvion Dutilleul, Francine ^b   Koken, Marcel H M ^b   De The, Hugues ^b   Staudt, Louis M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR FACTOR; PROTEIN LYSP 100; RETINOIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CELL NUCLEUS INCLUSION BODY; GENE FUSION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOGOLD STAINING; LYMPHOID CELL; PRIORITY JOURNAL;

EID: 0029845262     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.4.1423.bloodjournal8841423     Document Type: Article

References (60)

1. Spector DL: Macromolecular domains within the cell nucleus. Annu Rev Cell Biol 9:265, 1993
2. Koken MHM, Puvion-Dutilleu F, Guillermin MC, Viron A, Linares-Cruz G, Stuurman N, de long L, Szostecki C, Calvo F, Chomienne C, Degos L, Puvion E, de Thé H: The t(15; 17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 13:1073, 1994
3. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A: Retinoic acid regulates aberrant nuclear localization of PML-RARa in acute promyelocytic leukemia cells. Cell 76:345, 1994
4. Dyck JA, Maul GG, Miller WHJ, Chen JD, Kakizuka A, Evans RM: A novel macromolecular structure is a target of the promyelocytic-retinoic acid receptor oncoprotein. Cell 76:333, 1994
5. Ascoli C, Maul G: Identification of a novel nuclear domain. J Cell Biol 112:785, 1991
6. Lamond A, Carmo-Fonseca M: The coiled body. Trends Cell Biol 3:198, 1993
7. Daniel MT, Koken M, Romagne O, Barbey S, Bazarbachi A, Stadler M, Guillemin MC, Degos L, Chomienne C, de Thé H: PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82:1858, 1993
8. de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RARa fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
9. Goddard AD, Borrow J, Freemont PS, Solomon E: Characterization of a zinc finger gene disrupted by the t(15; 17) in acute promyelocytic leukemia. Science 254:1371, 1991
10. Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub M-P, Durand B, Lanotte M, Berger R, Chambon P: Structure, localization and transcriptional properties of two classes of retinoic acid receptor a fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J 11:629, 1992
11. Kakizuka A, Miller WHJ, Umesono K, Warrell RPJ, Frankel SR, Murty VVVS, Dmitrovsky E, Evans RM: Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor. PML. Cell 66:663, 1991
12. Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, LaCoco F, Grignani F, Pelicci PG: Structure and origin of the acute promyelocytic leukemia myl/RARa cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6:1285, 1991
13. Stuurman N, de Graaf A, Floore A, Josso A, Humbel B, De Jong L, van Driel R: A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci 101:773, 1992
14. Flenghi L, Fagioli M, Tomassoni L, Pilori S, Gambocorta M, Pacini R, Grignani F, Casini T, Ferrucci PF, Martelli MF. Pelicci P-G, Falini B: Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: Immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 85:1871, 1995
15. Terris B, Baldin V, Dubois S, Degott C, Flejou J-F, Henin D, Dejean A: PML nuclear bodies are general targets of inflammation and cell proliferation. Cancer Res 55:1590, 1995
16. Brasch K, Ochs RL: Nuclear bodies (NBs): A newly "rediscovered" organelle. Exp Cell Res 202:211, 1992
17. Everett RD, Maul GG: HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J 13:5062, 1994
18. Puvion-Dutilleul F, Chelbi-Alix MK, Koken M, Quignon F, Puvion E, de Thé H: Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body-associated PML protein. Exp Cell Res 218:9, 1995
19. Alcalay M, Zangrilli D, Pandolfi PP, Longo L, Mencarelli A, Giocomucci A, Rocchi M, Biondi A, Rambaldi A, Lo Coco F, Diverio D, Donti E, Grignani F, Pelicci PG: Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor a locus. Proc Natl Acad Sci USA 88:1977, 1991
20. Borrow JB: Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249:1577, 1990
21. de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A: The t(15; 17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 347:558, 1990
22. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
23. Mu A-M, Chin K-V, Liu J-H, Lozano G, Chang K-S: PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 14:6858, 1994
24. Liu J-H, Mu Z-M, Chang K-S: PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J Exp Med 181:1965, 1995
25. Koken M, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thépot J, Juhlin L, Degos L, Calvo F, de Thé H: The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315, 1995
26. Szostecki C, Guldner HH, Netter HJ, Will H: Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol 145:4338, 1990
27. Szostecki K, Krippner H, Penner E, Bautz FA: Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin Exp Immunol 68:108, 1987
28. Fusconi M, Cassani F, Govoni M, Caselli A, Farabegoli F, Lenzi M, Ballardini G, Zauli D, Bianchi FB: Anti-nuclear antibodies of primary biliary cirrhosis recognize 78-92-kD and 96-100-kD proteins of nuclear bodies. Clin Exp Immunol 83:291, 1991
29. Korioth F, Gieffers C, Maul GG, Frey J: Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J Cell Biol 130:1, 1995
30. Behrens TW, Jagadeesh J, Scherle P, Kearns G, Yewdell J, Staudt LM: JAW1, a lymphoid-restricted membrane protein localized to the endoplasmic reticulum. J Immunol 153:682, 1994
31. Scherle P, Behrens T, Staudt LM: Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc Natl Acad Sci USA 90:7568, 1993
32. Staudt LM, Dent A, Ma C, Allman D, Powell J, Maile R, Scherle P, Behrens T: Rapid identification of novel human lymphoidrestricted genes by automated DNA sequencing of subtracted cDNA libraries. Curr Top Microbiol Immunol 194:155, 1994
33. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
34. Xie K, Lambie E, Snyder M: Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol Cell Biol 13:6170, 1993
35. Smith DB, Johnson KS: Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase. Gene 67:67, 1988
36. Dutilleul F, Venturini L, Guillemin MC, de Thé H, Puvion E: Sequestration of PML and SP100 proteins in an intranuclear viral structure during herpes virus simplex type 1 infection. Exp Cell Res 221:448, 1995
37. Tanaka M, Herr W: Differential transcriptional activation by Oct-1 and Oct-2: Interdependent activation domains induce Oct-2 phosphorylation. Cell 60:375, 1990
38. Roth J: Post-embedding labeling on Lowicryl K4M tissue sections: Detection and modification of cellular components, in Tartikoff AM (ed): Methods in Cell Biology. New York, NY, Academic, 1989, p 513
39. Kadereit S, Gewert DR, Galabru J, Hovanessian AG, Meurs EF: Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins. J Biol Chem 268:24432, 1993
40. Koken MHM, Saib A, de Thé H: A C4HC3 zinc finger motif. C R Acad Sci 318:733, 1995
41. Aasland R, Gibson TJ, Stewart AF: The PHD finger: Implications for chromatin mediated transcriptional regulation. Trends Biochem Sci 20:56-59, 1995
42. Haynes SR, Dollard C, Winston F, Beck S, Trowsdale J, Dawid IB: The bromodomain: A conserved sequence found in human, Drosophila and yeast proteins. Nucleic Acids Res 20:2603, 1992
43. Le Douarin B, Zechel C, Gamier J-M, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R: The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020, 1995
44. Chrivia JC, Kwok RPS, Lamb N, Hagiwara M, Montminy MR, Goodman RH: Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855, 1993
45. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM: Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8:869, 1994
46. Fu XD, Maniatis T: Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature 343:437, 1990
47. Andrade LE, Chan EK, Raska I, Peebles CL, Roos G, Tan EM: Human autoantibody to a novel protein of the nuclear coiled body: Immunological characterization and cDNA cloning of p80-coilin. J Exp Med 173:1407, 1991
48. Lavau C, Marchio A, Fagioli M, Jansen J, Falini B, Lebon P, Grosveld F, Pandolfi P, Pelicci P, Dejean A: The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11:871, 1995
49. Guldner HH, Szostecki C, Grotzinger T, Will H: IFN enhances expression of sp100, an autoantigen in primary biliary cirrhosis. J Immunol 149:4067, 1992
50. Mazo AM, Huang DH, Mozer BA, Dawid IB: The trithorax gene, a trans-acting regulator of the bithorax complex in Drosophila, encodes a protein with zinc-binding domains. Proc Natl Acad Sci USA 87:2112, 1990
51. Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R: A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374:81, 1995
52. Lundblad JR, Kwok RP, Laurance ME, Harter ML, Goodman RH: Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85, 1995
53. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E: The t(4; 11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71:701, 1992
54. Tkachuk DC, Kohler S, Cleary ML: Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:691, 1992
55. Ruppert S, Wang EH, Tjian R: Cloning and expression of human TAFII250: A TBP-associated factor implicated in cell-cycle regulation. Nature 362:175, 1993
56. Hisatake K, Hasegawa S, Takeda R, Nakatani Y, Horikoshi M, Roeder RG: The p250 subunit of native TATA box-binding factor TFIID is the cell-cycle regulatory protein CCG1. Nature 362:179, 1993
57. Wang EH, Tjian R: Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250. Science 263:811, 1994
58. Peterson CL: The SW1-SNF complex: A chromatin remodeling machine? Trends Biochem Sci 20:143, 1995
59. Marcus GA, Silverman N, Berger SL, Horiuchi J, Guarente L: Functional similarity and physical association between GCN5 and ADA2: Putative transcriptional adaptors. EMBO J 13:4807, 1994
60. Mattaj IW, Boelens W, Izaurralde E, Jarmolowski A, Kambach C: Nucleocytoplasmic transport and snRNP assembly. Mol Biol Rep 18:79, 1993